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Abstract
Insulin-like growth factors (IGF) modulate placental and fetal growth and development
through nutrient sensing and endocrine signaling. We hypothesized that poor maternal nutrition
during gestation would alter IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 mRNA
expression in the ovine placenta, but would not affect IGF-II mRNA expression. Pregnant ewes
(n=57) were individually fed: 60% (restricted fed; RES), 100% (control fed; CON), or 140%
(over fed; OVER) of National Research Council requirements for TDN starting at day 30±0.2 of
gestation. Ewes were euthanized and cotyledon and caruncle samples were collected at days 45,
90, and 135 of gestation. Relative mRNA expression of IGF-I, IGF-II, IGFBP-2, and IGFBP-3
was quantified using real-time PCR. Data were analyzed using the MIXED procedure in SAS.
Relative IGF-I mRNA expression was less at day 45 than at days 90 and 135 in the caruncle (P <
0.001; d45: 0.96 ± 0.06, d90: 1.28 ± 0.06, d135: 1.38 ± 0.05). In the caruncle, IGFBP-2
expression was less at day 45 than at days 90 and 135 (P < 0.001; d45: 0.67 ± 0.20, d90: 1.90 ±
0.20, d135: 1.65 ± 0.18). There was no detectable impact of diet or time on IGF-II or IGFBP-3
expression in the caruncle (P > 0.12). In the cotyledon, IGF-I expression tended to be greater in
RES than OVER, which was similar to CON (P = 0.08; RES: 1.10 ± 0.06, OVER: 0.89 ± 0.07,
CON: 0.96 ± 0.07). Relative IGF-II mRNA expression was greater in RES than OVER
cotyledons (P = 0.01; RES: 1.96 ± 0.31, OVER: 0.54 ± 0.32, CON: 1.30 ± 0.35). Relative
IGFBP-2 mRNA expression decreased over time in the cotyledon (P < 0.001; d45: 1.26 ± 0.12,
d90: 0.93 ± 0.12, d135: 0.59 ± 0.11). Relative IGFBP-3 mRNA expression was less in RES than
in OVER or CON cotyledons (P = 0.009; RES: 0.03 ± 0.57, OVER: 3.62 ± 0.66, CON: 1.84 ±
0.64). In response to poor maternal diet, changes in IGF expression in the cotyledon were greater
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than in the caruncle, suggesting a potential mechanism by which maternal-fetal exchange may be
modified to restrict placental and fetal growth.
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Review of Literature
Introduction
Fetal development is a tightly regulated period of rapid growth. Therefore, modulations
to the intrauterine environment throughout gestation can negatively impact normal patterns of
fetal growth and development in offspring with persistent effects in the early postnatal period
through to maturity. Maternal nutrition, defined as the diet the mother consumes before breeding,
throughout gestation, and during lactation (American Journal of Public Health, 1973) has the
potential to influence the intrauterine environment by modulating the availability of nutrients,
growth factors, and hormones to the developing fetus (McMullen et al., 2005). Poor maternal
nutrition during gestation due to either overnutrition or undernutrition can have detrimental
anatomical and physiological effects on the offspring including decreased placental
vascularization, decreased birth weight, decreased muscle development, and increased fat
deposition (Redmer et al., 2004; Hoffman et al., 2014; Reed et al., 2014). These effects alter
postnatal growth of the offspring, indicating the importance of maternal nutrition during
gestation on offspring development.

Normal Placental Development
Ruminants have a cotyledonary placenta, which consists of a maternal contribution, the
caruncle, and a fetal contribution, the cotyledon. The caruncle and the cotyledon interdigitate at
discrete sites in the placenta called placentomes. Materno-fetal exchange of nutrients, gases, and
waste products occurs at the placentomes. As described by Reynolds et al. (1997), the fetal
membranes attach to the endometrial epithelium of the uterus on days 15 to 18 of gestation with
the interdigitation of the caruncle and the cotyledon beginning on day 23 of gestation. By day 30
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of gestation, the placentomes are well established and interdigitation is complete. The individual
placentomes and the placenta itself continue to grow in size until day 90 of gestation, when the
placenta achieves its maximum weight in sheep (Redmer et al., 2004). In sheep, the majority of
placental growth occurs in the first two-thirds of pregnancy, while approximately 90% of fetal
growth occurs in the last third of pregnancy (day 90 to day 145; Redmer et al., 2004).
Insulin-like growth factors (IGF) are nutritionally sensitive endocrine factors that regulate
fetal and placental growth and development. The IGFs regulate processes involved in
development by promoting cellular proliferation, differentiation, migration and aggregation, and
inhibiting apoptosis (Jones & Clemmons, 1995; Carter et al., 2005). IGF-I and IGF-II have
complimentary yet overlapping roles in optimizing nutrient partitioning to the fetus to optimize
growth and development. IGF-I regulates fetal growth by partitioning nutrients to the fetus in
response to nutrient availability (Sferruzzi-Perri et al., 2010). IGF-II acts directly on the placenta
to modulate the thickness and surface area of the materno-fetal interface (Sibley et al., 2004;
Sferruzzi-Perri et al., 2010). IGF-II is more abundant in maternal plasma than IGF-I irrespective
of reproductive state in many species, including sheep (Sferruzzi-Perri et al., 2010; Kadakia &
Josefson, 2016).
The bioavailability and biological actions of IGFs are regulated by IGF binding proteins
(IGFBP). All six of these binding proteins specifically bind to IGF-I and IGF-II; however, they
do so with differing affinities. While IGFBP-1, -3, and -4 bind IGF-I and IGF-II with similar
affinities, IGFBP-2, -5, and -6 preferentially bind to IGF-II (Rajaram et al., 1997; Reynolds et
al., 1997). It is well documented that IGFBPs function to limit the bioavailability of IGFs in
circulation; however, this family of six high-affinity binding proteins either inhibits or
potentiates the actions of IGFs on metabolism and mitogenesis based on the tissue and the post-
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translational modifications of individual IGFBPs (Rajaram et al., 1997; Reynolds et al., 1997;
Carter et al., 2005; Denley et al., 2005). The specific actions of the IGFBPs in placental tissue
are not yet fully understood. The IGFBPs are not only capable of modulating IGF-induced cell
proliferation but most of the IGFBPs have also been shown to act in IGF-independent pathways
(Rajaram et al., 1997; Denley et al., 2005; McMullen et al., 2005). Due to the complexity of the
IGFBP functions and the lack of understanding of the pathways with which they exert their IGFindependent effects, it is clear that the significance of changes in concentrations of the six IGFBP
in placental tissue requires further study.

Potential Mechanisms for Altered Placental Development
Poor maternal nutrition during gestation has been associated with a decrease in birth
weight of offspring and a decrease in placental weight (Gadd et al., 2000; Osgerby et al. 2004;
McMullen et al., 2005). Both high and low planes of maternal nutrition throughout gestation
have similar negative effects on the growth of the fetus (Gadd et al., 2000; Hoffman et al., 2014).
IGF-I concentration in plasma increases over the course of gestation (Carter et al., 2005). Plasma
IGF-I concentrations correlate with nutritional status, as IGF-I decreases in under-fed ewes
compared with control-fed ewes and increases in over-fed compared with control-fed ewes
(Gallaher et al., 1998; Gadd et al., 2000; McMullen et al., 2005). Relative mRNA expression of
IGF-I in placental tissue is not well described as IGF-I mRNA concentrations fall below the limit
of detection for in-situ hybridization assays in maternal nutrient restriction experiments shortly
after the invasion of the fetal villi (Reynolds et al., 1997; McMullen et al., 2005). While IGF-I
expression is both nutritionally and time-point sensitive in maternal plasma and serum, IGF-II
mRNA expression remains constant throughout gestation and is nutritionally independent in
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maternal plasma, maternal serum, and placental samples (Gadd et al., 2000; Osgerby et al., 2004;
McMullen et al., 2005).
Previous studies have presented conflicting results regarding the placental expression of
IGFBP-2 mRNA in ewes exposed to poor maternal nutrition. McMullen et al. (2005) and Gadd
et al. (2000) report that the concentrations of IGFBP-2 mRNA are reduced in nutrient restricted
ewes during early gestation and increased in ewes exposed to high plane rations in mid-gestation,
respectively. However, Osgerby et al. (2004) reported that mRNA expression of IGFBP-2
throughout gestation was nutritionally and time-point independent. While the effects of IGFBP-2
in the placenta are not well understood, IGFBP-2 has been shown to be mitogenic in IGFindependent pathways in human uterine endometrial epithelial cells and osteosarcoma cells
(Firth & Baxter, 2002).
IGFBP-3, the most abundant binding protein in placental tissue in women, exhibits both
nutritionally and time-point sensitive mRNA expression (Forbes & Westwood, 2008).
Concentrations of IGFBP-3 mRNA were reduced in the caruncles at day 90 in maternal
undernutrition experiments (Osgerby et al., 2004; McMullen et al., 2005). Relative mRNA
expression of IGFBP-3 was increased in fetal placental tissue of over-fed ewes compared with
control-fed ewes (Gadd et al., 2000). The direct effects of IGFBP-3 on placental tissue is not
well understood; however, IGFBP-3 has been reported to have IGF-independent growth
inhibitory effects in IGF Receptor 1-knockout mice (Firth & Baxter, 2002). In opossum kidney
cells, intact IGFBP-3 inhibited cell growth due to direct nuclear actions (Rechler & Clemmons,
1998). Several studies have found evidence that intact IGFBP-3 has a mediating role in a wide
range of growth effectors, such as TGFβ, retinoic acid, antiestrogens, vitamin D analogs, and
TNFα (Firth & Baxter, 2002). Fragments and proteolyzed forms of IGFBP-3, which have little to
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no affinity for IGFs, have also been shown to inhibit mitogenesis in the fibroblasts of chick
embryos and mice via IGF-independent pathways (Firth & Baxter, 2002).

Objectives and Hypothesis
The placenta is an important determinant of fetal growth rate. Therefore, relative
expression of IGFs and IGFBPs in the placenta can be used as an indicator of the effect of
environmental stressors on the growth and development of the fetus throughout gestation. The
objective of this study is to determine alterations in transcription of IGF-I, IGF-II, IGFBP-2, and
IGFBP-3 by poor maternal nutrition throughout gestation. This study is the first comprehensive
study to describe the effects of both undernutrition and overnutrition on the relative mRNA
expression of IGFs and IGFBPs over the course of gestation. Given the great implications of
maternal stressors, including poor maternal nutrition during gestation, on postnatal growth and
overall health of the animal, it is important to understand the effects of maternal stressors on fetal
development. Examining the effects of both underfeeding and overfeeding ewes throughout
gestation provides further insight into optimal nutrient requirements for lamb production as well
as the duration a fetus can be exposed to poor maternal nutrition before the onset of the
detrimental effects associated with poor maternal nutrition. Based on results of related studies,
we hypothesized that poor maternal nutrition during gestation would cause a change in the
mRNA expression of IGF-I, IGFBP-2, and IGFBP-3 in the ovine placenta, but would not affect
the mRNA expression of IGF-II.
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Materials and Methods
Animals and Sample Collection
All animal procedures were reviewed and approved by the University of Connecticut’s
Institutional Animal Care and Use Committee (protocol number: A13-059).
Animal procedures were previously reported in Pillai et al. (2017). For this project,
multiparous Western White-Faced ewes (n= 57) were randomly assigned one of three diets:
restricted (RES; 60%), control (CON, 100%), or over-fed (OVER; 140%) based on National
Research Council requirements for total digestible nutrients starting at d30 ± 0.2 of gestation
(Figure 1). Ewes were euthanized via intravenous injection of Beuthanasia-D Special (0.22
mL/kg; Merck Animal Health; Summit, NJ) at days 45, 90, and 135 of gestation. Placental
samples from the cotyledon and caruncle (n= 4 to 7 ewes per treatment per time point) were
collected during necropsy, immediately snap frozen in liquid nitrogen, and stored at -80°C.
While fetal tissues were also collected at parturition, placental tissue was not recovered.

RNA Extraction
Tissue was homogenized using a Qiagen TissueLyser Bead Homogenizer (Qiagen,
Valencia, CA). Total RNA was extracted using a standard phenol-chloroform extraction. The
quantity of RNA was determined using a Nanodrop spectrophotometer (Thermoscientific,
Lafayette, CO).

Real-Time Quantitative Polymerase Chain Reaction
Isolated RNA was reverse transcribed to complimentary DNA using a SuperScript III kit
(Invitrogen, Carlsbad, CA) according to manufacturer’s protocol. Briefly, 1 L OligodT primer
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(Invitrogen), 1,000 ng total RNA, 1 L dNTP mix (Invitrogen), and sterile water were mixed to a
total reaction volume of 10 L. The mixture was heated to 65C for 5 minutes and incubated on
ice for 1 minute. A cDNA master mixture composed of 4 L of 5x First-Strand Buffer
(Invitrogen), 1 L DDT (Invitrogen), 1 L RNase Out (Invitrogen), 1 L SuperScript III
(Invitrogen), and 5 L RNase Free water (Invitrogen), was then added to the reaction. Reverse
transcription was performed with a standard protocol starting at 25C for 5 minutes, 50C for 60
minutes, and 70C for 15 minutes. Complimentary RNA was removed by adding 2 units of
Escherichia coli RNase H to the reaction and incubating the mixture at 37C for 60 minutes.
Primers were designed for genes involved in the somatotropic axis (IGF-I, IGF-II, IGFBP-2, and
IGFBP-3; Table 1) using NCBI BLAST and synthesized by Integrated DNA Technologies
(Coralsville, IA). All primers with the exception of IGF-II were validated by Hoffman et al.
(2014). The IGF-II primer was validated by Xing et al. (2014). Real-time quantitative
polymerase chain reaction (RT-qPCR) was performed using SYBR Green Master Mix
(Invitrogen) and the ABI 7900 HT Fast Real-time PCR machine (Applied Biosystems, Foster
City, CA) according to the manufacturer’s protocol. The total volume of the reaction mixture
was 25 L containing 12.5 L SYBR Green Master Mix (Invitrogen), 0.225 L each of 10 nM
forward and reverse primer (Integrated DNA Technologies), 7.05 L of nuclease free water, and
5 L generated cDNA. Real-time qPCR was performed using standard cycling conditions (stage
1: 50C for 2 minutes, stage 2: 95C for 10 minutes, stage 3: 95C for 15 seconds and 60C for 1
minute for 40 cycles). Ct values were utilized to calculate the Ct values to determine changes
in gene expression. Gene expression was normalized to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), as its expression did not vary between treatments or time points. Gene
expression was expressed as fold change relative to controls at day 45.
10
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Statistical Analysis
Data were analyzed using the PROC MIXED procedure (SAS Institute, Inc., Cary, NC)
with main effects of diet, time point, and the interaction of diet and timepoint. The PDIFF
statement was utilized to determine differences between means. Data are reported as mean ±
SEM, with P < 0.05 considered significant and 0.05 < P < 0.10 considered a tendency.

Results
Day of gestation altered IGF-I and IGFBP-2 mRNA expression in the caruncle.
In the caruncle, relative IGF-I mRNA expression was less at day 45 than at days 90 and
135 of gestation (P < 0.001; d45: 0.96 ± 0.06, d90: 1.28 ± 0.06, d135: 1.38 ± 0.05; Figure 2).
Relative mRNA expression of IGFBP-2 was less at day 45 than at days 90 and 135 of gestation
(P < 0.001; d45: 0.67 ± 0.20, d90: 1.90 ± 0.20, d135: 1.65 ± 0.18; Figure 2). There was no
detectable impact of time on relative mRNA expression of IGF-II or IGFBP-3 in the caruncle (P
> 0.05; Figure 2). Dietary treatment did not significantly alter relative mRNA expression of IGFI, IGF-II, IGFBP-2, or IGFBP-3 in the caruncle (P > 0.05).

Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon.
In the cotyledon, expression of IGF-I tended to be greater in RES than OVER with CON
intermediate (main effect of diet: P = 0.08; RES: 1.10 ± 0.06, OVER: 0.89 ± 0.07, CON: 0.96 ±
0.07; Figure 3). Relative IGF-II mRNA expression was greater in RES than OVER cotyledons
with CON intermediate (main effect of diet: P = 0.01; RES: 1.96 ± 0.31, OVER: 0.54 ± 0.32,
CON: 1.30 ± 0.35; Figure 3). Relative IGFBP-3 mRNA expression was less in RES than in
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OVER or CON cotyledons (main effect of diet: P = 0.009; RES: 0.03 ± 0.57, OVER: 3.62 ±
0.66, CON: 1.84 ± 0.64; Figure 3). Maternal diet had no detectable effect on relative mRNA
expression of IGFBP-2 in the cotyledon (P > 0.05; Figure 3).

Day of gestation altered IGFBP-2 mRNA expression in the cotyledon.
Relative IGFBP-2 mRNA expression decreased over time in the cotyledon (P < 0.001;
d45: 1.26 ± 0.12, d90: 0.93 ± 0.12, d135: 0.59 ± 0.11; Figure 4). There were no significant
detectable effects of time on relative mRNA expression of IGF-I, IGF-II, or IGFBP-3 in the
cotyledon (P > 0.05; Figure 4).
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Table 1. Primer sequences for real-time qPCR.
Gene

Primer Sequences

IGF-I

References
Hoffman et al., 2014

Forward

5’-CCAGACAGGAATCGTGGATG-3’

Reverse

5’- ACTTGGCGGGCTTGAGAG-3’

IGF-II

Xing et al., 2014

Forward

5’-TTCTTCCAATCTGACACCTG-3’

Reverse

5’-AGGCAGGGCGATCAGCGGACGGTGA-3’

IGFBP-2

Hoffman et al., 2014

Forward

5’- CCCTACACATCCCCAACTGT-3’

Reverse

5’- CAGTGTTGGGGTTCACACAC-3’

IGFBP-3

Hoffman et al., 2014

Forward

5’- CAGAGCACAGACACCCAGAA-3’

Reverse

5’- CACAGTTGGGAATGTGGATG-3’

GAPDH

Hoffman et al., 2014

Forward

5’-GGCGTGAACCACGAGAAGTATAA-3’

Reverse

5’- CCTCCACGATGCCAAAGTG-3’
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Figure 1. Experimental Design. Experimental design, adapted from Pillai et al. (2017).
Pregnant ewes (n = 57) were randomly assigned to one of three dietary treatments beginning at d
30 ± 0.2 of gestation (CON = 100% NRC; RES = 60% NRC; OVER = 140% NRC). At day 45,
90, or 135 of gestation, ewes were euthanized and placental samples were collected during
necropsy. The placental samples were dissected into two distinct tissues: the caruncle (car) and
cotyledon (cot). The samples were placed into individual tubes, snap frozen in liquid nitrogen,
and stored at -80°C (n = 4 to 7 ewes per treatment combination per tissue).
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Figure 2. Day of gestation altered IGF-I and IGFBP-2 mRNA expression in the caruncle.
Gene expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and
IGFBP-3 was analyzed in the caruncle. Relative mRNA expression of IGF-I and IGFBP-2 were
less at day 45 than at days 90 and 135 (P < 0.001 for both genes). Data are expressed as mean ±
SEM. Within each gene, means with different letters are different at P < 0.05.
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Figure 3. Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon.
Gene expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and
IGFBP-3 was analyzed in the cotyledon. Relative IGF-II mRNA expression was greater in RES
than OVER cotyledons (main effect of diet: P = 0.01). Relative IGFBP-3 mRNA expression was
less in RES than in OVER or CON cotyledons (main effect of diet: P = 0.009). Data are
expressed as mean ± SEM. Within each gene, means with different letters are different at P <
0.05.
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Figure 4. Day of gestation alters IGFBP-2 mRNA expression in the cotyledon. Gene
expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and IGFBP3 was analyzed in the cotyledon. Relative IGFBP-2 mRNA expression decreased over time (P <
0.001). Data are expressed as mean ± SEM. Within each gene, means with different letters are
different at P < 0.05.
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Discussion
Previous studies investigating the effects of poor maternal nutrition during gestation on
placental expression of IGFs and IGFBPs have focused on either restricted- (Gallaher et al.,
1998; Osgerby et al., 2004; McMullen et al., 2005) or over-feeding (Gadd et al., 2000).
Additionally, the models utilized in previous experiments studied only the acute effects of poor
maternal nutrition (Gallaher et al., 1998; Osgerby et al., 2004; McMullen et al., 2005). The aim
of this study was to determine the effects of both over- and under-feeding throughout gestation
on placental mRNA expression of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 in both the caruncle
and the cotyledon. The caruncle and cotyledon were analyzed separately to identify potential
mechanisms through which changes in expression of the IGFs and IGFBPs induced by poor
maternal nutrition in either of these tissues may contribute to the restricted placental and fetal
growth observed in previous studies (Gadd et al., 2000; Osgerby et al., 2004; Redmer et al.,
2004; Carter et al., 2005; Pillai et al., 2017). We found that maternal diet altered the expression
of IGF-II and IGFBP-3 in the cotyledon, but did not alter expression of any of the IGFs or
IGFBPs studied in the caruncle.

Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon.
In this study, relative IGFBP-3 mRNA expression was less in RES than in OVER or
CON cotyledons. This result is consistent with the observations of Gallaher et al. (1998) in
which IGFBP-3 concentrations were decreased in fetal plasma in under-fed ewes. This result is
also consistent with an observed reduction of plasma IGFBP-3 in underfed guinea pigs (Carter et
al., 2005). IGFBP-3 has an equal binding affinity for IGF-I and IGF-II and binds 95% of
circulating IGF-I and IGF-II (Reynolds et al., 1997). The decrease in placental expression of
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IGFBP-3 in restricted-fed ewes concurrent with the increase in IGF-II would allow for an
increase in the bioavailability of IGF-II. The increase in bioavailable IGF-II would then allow for
an increase in placental surface area and decrease in placental thickness, similar to those effects
observed in guinea pigs (Roberts et al., 2008; Forbes & Westwood, 2008; Forbes & Westwood,
2010; Sferruzzi-Perri et al., 2010). Roberts et al. (2008) reported that plasma IGF-II
concentrations correlate positively with placental surface area and negatively with placental
thickness in guinea pigs. When interpreted in this context, the increase in IGF-II expression in
RES cotyledons compared with OVER cotyledons is intuitive physiologically. A restricted-fed
ewe has less nutrients available for the fetus and the ewe will partition nutrients to the fetus at the
expense of her own requirements. The increase in placental expression of IGF-II would cause a
concurrent increase in placental surface area and decrease in the thickness of the placenta,
allowing for the passage of nutrients from maternal to fetal circulation to occur at a more rapid
rate. Similarly, the decrease in IGF-II expression in the OVER cotyledons would decrease
placental surface area while increasing barrier thickness. The decrease in the rate of passage of
nutrients from maternal to fetal circulation due to these physiological changes to the placenta
would protect the fetus from over-exposure to nutrients, allowing for a more optimal intrauterine
environment for growth. IGFBP-2 expression was not impacted by maternal diet in this study,
potentially allowing an increase in bioavailability of IGF-II which may result in the above
described physiological changes in the placenta. However, the nutritional dependence of IGF-II
expression in the cotyledons is contradictory to in-situ hybridization studies that indicate that
placental expression of IGF-II is nutritionally independent (Gadd et al., 2000; Osgerby et al.,
2004; & McMullen et al., 2005). This discrepancy in results could be due to the different
methods utilized in the experiments. The in-situ hybridization studies utilized an image analysis
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system and quantified the results using optical density units. In this study, however, we utilized
real-time qPCR which is more sensitive and accurate in quantifying the concentrations of
compounds such as IGFs and IGFBPs (Biedermann et al., 2004; Thermo Fisher Scientific Inc.,
2020).
IGFBP-3 has an equal binding affinity for IGF-I and IGF-II and binds 95% of circulating
IGF-I and IGF-II (Reynolds et al., 1997). In this study, relative IGFBP-3 mRNA expression was
less in RES than in OVER or CON cotyledons. This result is consistent with the observations of
Gallaher et al. (1998) in which IGFBP-3 concentrations were decreased in fetal plasma in underfed ewes and with an observed reduction of plasma IGFBP-3 in underfed guinea pigs (Carter et
al., 2005). The decrease in placental expression of IGFBP-3 in restricted-fed ewes concurrent
with the increase in IGF-II would allow for an increase in the bioavailability of IGF-II. The
increase in bioavailable IGF-II would then allow for an increase in placental surface area and
decrease in placental thickness, similar to those effects observed in guinea pigs, which would
allow for the limited nutrients of the RES ewes to be more easily passed via the feto-maternal
interface of the placentome to the fetus (Roberts et al., 2008; Sferruzzi-Perri et al., 2010). The
nutrients would be partitioned to the fetus to allow for the fetus to grow at its maximum potential
at the expense of the nutrient-restricted ewe.

Day of gestation altered IGF-I in the caruncle and IGFBP-2 mRNA expression in both the
caruncle and cotyledon.
Over the course of gestation, fetal demands for nutrients increase in preparation for the
rapid period of fetal growth during late gestation (Redmer et al., 2004). Maternal IGF-I serum
concentrations increase to accommodate the changes in nutrient demand, partitioning more
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nutrients to the fetus to allow for optimal growth of the fetus at expense of the ewe. Previous
studies indicate that maternal serum IGF-I concentrations increase over gestation (Carter et al.,
2005). Relative mRNA expression of IGF-I was less at day 45 than at days 90 and 135 in the
caruncle. This change in mRNA expression was not observed in the cotyledon. The observed
change in IGF-I expression in the maternal but not the fetal contribution to the placentome is
consistent with the idea that IGF-I is essential in controlling nutrient partitioning (Sferruzzi-Perri
et al., 2010). The relative expression of IGFBP-2 in the caruncle mirrored the changes observed
in IGF-I expression. While IGFBP-2 preferentially binds to IGF-II, it still has the capacity to
bind to IGF-I and mitigate its bioavailability (Rajaram et al., 1997; Reynolds et al., 1997). The
expression of IGF-II has been characterized as being time-point independent during gestation in
sheep (Gadd et al., 2000; Osgerby et al., 2004; & McMullen et al., 2005). These results suggest
that IGFBP-2 may be expressed in a similar pattern as IGF-I in the caruncle to maintain IGF-II
concentrations throughout gestation while having a lesser effect on the bioavailability of IGF-I.
The increase in IGFBP-2 decreases the bioavailability of IGF-II while having a more minimal
impact on the bioavailability of IGF-I. This allows IGF-I concentrations to increase to meet the
nutritional demands of the fetus throughout gestation while ensuring its concentrations remain
within an appropriate physiological range.
The majority of fetal growth occurs in the last third of pregnancy (day 90 to 145; Redmer
et al., 2004). IGF-II regulates fetal growth by acting directly on the placenta to influence nutrient
delivery to fetal cells (Sferruzzi-Perri et al., 2010). IGFBP-2 preferentially binds IGF-II, which
plays an important role in regulating the surface area and thickness of the placenta as well as
stimulating proliferation, differentiation, migration and aggregation of fetal cells (Jones &
Clemmons, 1995; Sibley et al., 2004; Carter et al., 2005; Sferruzzi-Perri et al., 2010). Taken
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together, the decrease in fetal mRNA expression of IGFBP-2 throughout gestation in this study
with its lowest relative expression during late gestation (day 135) could increase the
bioavailability of fetal IGF-II, allowing for a greater influence of IGF-II on fetal growth and
development during the period of rapid growth in late gestation.

Conclusion
In conclusion, poor maternal nutrition during gestation influenced the relative mRNA
expression of IGF-I, IGF-II, and IGFBP-3 in the cotyledon, but had no effect on IGF-I, IGF-II,
IGFBP-2, or IGFBP-3 expression in the caruncle or IGFBP-2 expression in the cotyledon. The
IGF system was altered to a greater extent in the cotyledon than in the caruncle in response to
poor maternal diet, suggesting a potential mechanism by which maternal-fetal exchange may be
modified to restrict placental and fetal growth. Relative mRNA expression of IGFs and IGFBPs
in response to poor maternal nutrition warrants further study as there are few studies of this kind
and the results of this study conflict with those found in experiments studying the effect of poor
maternal nutrition on plasma concentration or in-situ hybridization of IGFs and IGFBPs. Future
studies should also measure protein concentrations in placental tissue, fetal circulation, and
maternal circulation to determine if the changes in transcription observed in this study are
reflected in the protein concentrations. Further studies should investigate the effects both overand under-feeding over the course of gestation on relative expression of IGF-I, IGF-II, and all six
of the IGFBPs in both the cotyledon and the caruncle to allow for greater understanding of the
interactions of the IGFs and IGFBPs in the placentome. Additional work should also focus on
IGFBP-4, as it and its protease are associated with pregnancy and dysregulation of plasma
IGFBP-4 in humans has been shown to contribute significantly to the development of fetal
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growth restriction (Qiu et al., 2012). The results of this study indicate that the IGF system in the
cotyledon was altered in reaction to poor maternal diet to maintain the bioavailable IGF-I and
IGF-II concentrations in the placenta within appropriate physiological ranges to in an attempt to
counteract fetal growth restriction caused by nutritional insult. Poor maternal nutrition has been
correlated with restricted fetal and placental growth throughout gestation, resulting in a decrease
in the productive part of the animal, the muscle. Therefore, it is important to understand the
mechanisms and factors that contribute to restricted fetal growth caused by poor maternal
nutrition.
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